

| Revenue | $10 - $100 million See Exact Annual Revenue |
|---|---|
| Employees | 10 - 100Exact Company Size |
| Primary Industry | 5417 Scientific Research & Development Services |
| Additional NAICS Codes | 325412 Pharmaceutical Preparation Manufacturing |
| Address | 2 Atlantic Avenue 6th Floor Boston, MA 02110 |
| Spectrum Pharmaceuticals | Revenue Est. ($ Million) | Growth Rate (%) | # Employees |
|---|---|---|---|
| 2025 | $10 - $100 million Details in Premium Report | ||
| 2024 | |||
| 2023 | |||
| 2021 | |||
| 2020 | |||
| 2019 | |||
|
1-Year Growth Rate: 3-Year Growth Rate (CAGR): | ![]() |
| Spectrum Pharmaceuticals P&L | $ Millions |
|---|---|
| Revenue (Sales) | ![]() |
| Cost of Goods Sold | |
| Gross Profit | |
Operating Expenses | |
| Advertising | |
| Salaries and wages | |
| Other Operating Expenses | |
| Total Operating Expenses | |
| Operating Income | |
| EBITDA | |
| EBIT (Earnings Before Interest and Taxes) | |
| Net Profit | |
| Trademark | Date |
|---|---|
| ROLVEDON Pharmaceutical preparations for the treatment and prevention of cancer and related symptoms; Pharmaceutical preparations for the treatment of neutropenia | 01/10/2022 |
| EXIANT Educational services, namely, development and dissemination of printed educational materials of others in the fields of pharmaceutical products and treatment of medical disorders; conducting classes, seminars, conferences, and workshops in the field of the use of prescription pharmaceutical products for medical disorders, in the field of cancer, patient care; educational and entertainment services, namely, providing a motivational and educational speaker featuring information regarding medical disorders; training services in the field of patient support services relating to treatment of medical disorders; providing on-line electronic newsletters delivered by email, and blogs in the medical, pharmaceutical and health fields; none of the foregoing relating to diagnostic products or diagnostics | 04/11/2019 |
| KHAPZORY Pharmaceutical preparation for the treatment of folic deficiency, methotrexate rescue, impaired methotrexate elimination, inadvertent overdosage of folic acid antagonists, osteosarcoma, and colorectal indications that is precipitate free when mixed other folate antagonists | 10/23/2018 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| LEIDOS | Denver, CO | 100 |
| NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA | Albuquerque, NM | 30 |
| INC RESEARCH | Raleigh, NC | 27 |
| RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK | Albany, NY | 17 |
| FLUOR MARINE PROPULSION | West Mifflin, PA | 15 |
| SYNEOS HEALTH | Raleigh, NC | 13 |
| ILLUMINA | San Diego, CA | 12 |
| UT-BATTELLE | Oak Ridge, TN | 11 |
| PRA HOLDINGS | Raleigh, NC | 11 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| BROAD INSTITUTE | Cambridge, MA | 100 |
| BEIGENE USA | Cambridge, MA | 69 |
| ALNYLAM PHARMACEUTICALS | Cambridge, MA | 52 |
| SAGE THERAPEUTICS | Cambridge, MA | 47 |
| INTELLIA THERAPEUTICS | Cambridge, MA | 35 |
| IPSEN BIOPHARMACEUTICALS | Cambridge, MA | 34 |
| Company | Headquarters | Revenue ($ MM) |
|---|---|---|
| AG MEDNET | Boston, MA | 100 |
| NORTHFIELD INFORMATION SERVICES | Boston, MA | 23 |
| GLOBAL NEWS ENTERPRISES | Boston, MA | 0 |
| Company | Revenue ($ MM) |
|---|---|
![]() | |